A Technology Patent License Agreement Review Attorney Helps Manage Licensing Risks

Licenses generally fall into exclusive, non-exclusive, or sole grants. An exclusive license may restrict the licensor from practicing the patented technology within the defined scope, depending on the rights expressly reserved in the agreement. Conversely, a non-exclusive license permits the licensor to grant identical rights to third parties.

Field-of-use restrictions limit technology exploitation to specific industries, product categories, or technical applications. A licensing agreement must clearly articulate whether future iterations, improvements, or derivative works belong to the licensor or licensee.

Downstream commercialization often relies on sublicensing authority. When an agreement permits sublicensing, licensors typically impose strict conditions, such as:

Mandating that sublicenses match or exceed the main agreement's risk-allocation standards,

Imposing joint liability on the primary licensee for defaults committed by sub-licensees, and

Requiring prior written consent for any sub-licensee selection or contract assignment.

Without clear sublicensing terms, cross-border distribution networks and joint development ventures face operational disruptions.

Licensor indemnification provisions protect licensees if a third party alleges that the licensed technology infringes on existing patent rights. However, licensors frequently attempt to limit indemnification through liability caps, disclaimers of consequential damages, or specific carve-outs.

Common liability carve-outs shift risk back to the licensee when infringement arises from:

• Modifications made to the technology by the licensee without licensor approval,
• Combination of the licensed patent with third-party software, hardware, or processes, or
• Failure to implement non-infringing updates provided by the licensor.

Licensors generally disclaim warranties regarding patent validity and non-infringement. Licensees should seek affirmative representations that the licensor owns the patent, holds full authority to grant rights, and maintains no knowledge of pending litigation or conflicting third-party claims.

If a licensed patent is declared invalid by the U.S. Patent and Trademark Office or a federal court, the agreement should explicitly outline contractual remedies, such as immediate royalty adjustments, renegotiation rights, or contract termination.

Royalty calculations vary based on net sales, fixed per-unit fees, or milestone achievements. Defining net sales requires careful enumeration of allowable deductions, such as shipping costs, taxes, or customary trade discounts.

Milestone payments occur frequently in advanced technology sectors, triggering mandatory compensation upon reaching technical, regulatory, or commercialization benchmarks.

Licensors routinely preserve audit rights to inspect licensee financial records. Audit provisions should establish reasonable advance notice, define the scope of records subject to inspection, and specify how often an audit may occur. The agreement should also state whether audit costs shift to the licensee when a defined underpayment threshold is exceeded.

Cross-border licensing agreements should address applicable withholding taxes and clarify whether royalty payments are calculated gross or net of required tax deductions. The parties should also consider how tax documentation, treaty benefits, and payment responsibilities affect the actual amount received by the licensor.

A license may permit termination after a material breach, a change of control, or specified financial events. Rather than relying on automatic termination language, the agreement should define which events trigger termination and whether the affected party has notice and an opportunity to cure.

Post-termination provisions should also address existing inventory, outstanding royalties, confidential information, technical materials, and sublicenses. Where continued sales are permitted for a limited period, the agreement should specify the scope of those sell-off rights and any continuing payment obligations.

Cross-border technology licenses may trigger export control or sanctions requirements depending on the technology, parties, destination, end user, and intended use. EAR requirements may apply to certain commercial and dual-use items, software, and technology, while ITAR separately regulates covered defense articles, technical data, and defense services. OFAC restrictions may also affect transactions involving sanctioned countries, entities, or individuals.

The agreement should allocate responsibility for required licenses, classifications, screening, and regulatory approvals before controlled technology or technical data is transferred. A coordinated compliance review can help identify these restrictions before they interfere with performance of the license.